AI and its generative capabilities have gained significant attention, particularly in the field of biomedicine, since ChatGPT's rise to prominence in late 2022. AI is being used in various medical technologies to provide medical information, aid disease diagnosis, accelerate drug development, and improve surgical procedures.
 

AI plays a crucial role in delivering medical information. For example, Google's AI called Med-PaLM has received a remarkable 92.6% approval rating from clinical physicians and has been published in Nature in July 2023. Taiwan's dentall.ai, powered by ChatGPT's Large Language Models (LLMs) and deep learning, caters to dentistry's specific clinical needs. AI is also being used for vision testing, detecting abnormal respiratory sounds, and enabling remote patient care.
 

AI has sped up progress in drug development. The AI software RFdiffusion has overcome previous limitations in protein design, allowing custom creation of high-symmetry protein structures for specific requirements. AnHorn Medicines has focused on AI drug discovery for protein degradation drugs, along with applications in targeted drugs, immunological disease treatments, sleeping pills, and vaccines.
 

AI is invaluable in aiding disease diagnosis, enabling precise diagnoses and individualized treatment plans. Alpha Intelligence Manifolds's DeepXray™ uses X-ray imaging with high accuracy to diagnose chronic bone ailments like osteoarthritis and osteoporosis. Applied BioCode (6598.TW) uses digital biomarker technology for simultaneous multi-pathogen analysis, improving patient treatments. AI also helps diagnose cancer, retinal disorders, neurological diseases, fractures, heart disease, strokes, and more.
 

In surgical support, Brain Navi Biotechnology's NaoTrac, an Asian neurosurgical navigation robot, stands out. NaoTrac combines high-precision technology with surgeons' expertise to streamline surgical procedures and shorten the learning curve, leading to minimally invasive surgery and improved outcomes. This technology is CE-certificated and approved by Taiwan FDA.
 
In conclusion, AI has undeniable potential to revolutionize healthcare and improve quality of life. However, it's essential to maintain a critical mindset and evaluate AI-provided information carefully.
 
Check out our editors' picks for AI development articles from January to July of the current year, focusing on the latest applications of AI in biomedicine.
 

臺灣首創手術導航機器人攻美 鈦隼將遞FDA 510(k)申請
https://news.gbimonthly.com/tw/audiovisual/show.php?num=60423&page=2&category=&kw=AI
 

Google醫學問答AI Med-PaLM微調版獲評92.6% 媲美醫療專家
https://news.gbimonthly.com/tw/article/show.php?num=60494&page=2&category=&kw=AI
台灣牙e通以AI數位轉型 打造影像辨識、病歷系統牙科宇宙
https://news.gbimonthly.com/tw/audiovisual/show.php?num=60462&page=2&category=&kw=AI
 

AI開發平台助力新藥開發效率 安宏屢獲資本市場肯定
https://news.gbimonthly.com/tw/audiovisual/show.php?num=59730&page=5&category=&kw=AI
安醫生技人工智慧平台 加速蛋白質新藥開發
https://news.gbimonthly.com/tw/audiovisual/show.php?num=59729&page=5&category=&kw=AI
4失眠模式動物、2人體臨床驗證有效助眠
工研院導入AI 開發鹿角靈芝配方素材
https://news.gbimonthly.com/tw/magazine/article_show.php?num=57720&page=8&category=&kw=AI
 

揭難診斷罕見血癌！AI為骨髓增生性腫瘤診斷利器？
https://news.gbimonthly.com/tw/celebrity/show.php?num=46251&page=3&kind=8
陽明交大黃俊達團隊3國際醫學影像AI競選奪獎
https://news.gbimonthly.com/tw/article/show.php?num=58448&page=7&category=&kw=AI
AI Labs、微軟簽MOU！助腦轉移AI融合ChatGPT佈署美西
https://news.gbimonthly.com/tw/article/show.php?num=58090&page=8&category=&kw=AI
大廠青睞！Taiwan AI Labs 腦轉移瘤分析AI 獲GE醫療導入MRI
https://news.gbimonthly.com/tw/article/show.php?num=57403&page=9&category=&kw=AI
采風智匯高效長時AI助理 智慧方案助診慢性骨疾、心血管病
https://news.gbimonthly.com/tw/audiovisual/show.php?num=60429&page=2&category=&kw=AI
縮短90%判讀時間、一次測15種心血管疾病
巨量移動心電圖AI辨識SaaS服務 預計 2023 年 FDA 取證
https://news.gbimonthly.com/tw/magazine/article_show.php?num=55803&page=12&category=&kw=AI
引英特爾、羅氏結盟 共同打造次世代病理生態鏈！
捷絡生技3D數位病理+ AI判讀 2023上半年攻FDA醫材證
https://news.gbimonthly.com/tw/magazine/article_show.php?num=55802&page=12&category=&kw=AI
宏基智醫攜手永信 擴大推AI糖尿病視網膜病變醫材
https://news.gbimonthly.com/tw/article/show.php?num=58736&page=7&category=&kw=AI
台首款腦波AI獲美FDA上市！宏智生醫「腦退化評估系統 」即早揪出失智風險
https://news.gbimonthly.com/tw/article/show.php?num=57745&page=9&category=&kw=AI
 

許世明：AI協助臺灣精準健康產業大未來
https://news.gbimonthly.com/tw/invest/show.php?num=58906&page=6&category=&kw=AI

(Editor: Shirley Cheung)